Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

U.K., U.S. Agree To Deals With Pharma Companies To Purchase Any Successful Coronavirus Vaccines; Pfizer Negotiating With E.U. On Vaccine Contract; Media Outlets Report On Other COVID-19 R&D News

Financial Times: U.K. strikes deal for 60m Covid-19 vaccine doses with Sanofi and GSK “The U.K. has agreed to buy up to 60m doses of a vaccine being developed by Sanofi and GlaxoSmithKline if the companies are able to prove its efficacy against Covid-19 in clinical trials to start in…

2 Experimental Coronavirus Vaccines Move To Large-Scale Trials In Final Testing Phase

NPR: 2 Coronavirus Vaccines Move To Final Testing Phase “Two companies announced [Monday] that they are beginning widespread testing of potential coronavirus vaccines. One comes from a collaboration between the National Institutes of Health and the U.S. biotech company Moderna. The other is from a collaboration between the pharmaceutical giant…

More News In Global Health

Devex: Q&A: Tackling the global NCD burden (7/27). Devex: Q&A: Taking on NGO leadership in the COVID crisis (Cornish, 7/27). Devex: How to empower health workers: Lessons learned from ‘On the Frontlines’ (Donback, 7/24). Global Press Journal: Cervical Cancer Claims Lives as Hospital Backlog Grows in Zambia (Phiri, 7/26). Global…

Trump Administration To Award $472M More To Moderna For Coronavirus Vaccine Candidate Development; Media Outlets Report On Other COVID-19 Vaccine News

POLITICO: Trump administration invests $472M more in Moderna vaccine candidate “The Trump administration is going to pump another $472 million into expanding Moderna’s clinical trial to test the safety and efficacy of its coronavirus vaccine candidate…” (Roubein, 7/26). Reuters: Moderna gets further $472 million U.S. award for coronavirus vaccine development…

U.S. Agrees To $1.95B Deal With Pfizer, BioNTech To Provide Initial 100M Doses Of Successful Coronavirus Vaccine; NIH To Begin Multiple Large Clinical Trials For Vaccines, Therapies

The Hill: U.S. negotiates 100 million doses of coronavirus vaccine from Pfizer that will be free to Americans “Pfizer and BioNTech, a German biotech company, announced Wednesday that the U.S. has reached a $1.95 billion deal with them for an initial order of 100 million doses of their coronavirus vaccine.…

5 Pharmaceutical Company Executives Discuss Plans For Cost, Distribution, Safety Of Potential COVID-19 Vaccines In U.S. House Investigative Subcommittee Hearing

New York Times: Some Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine “Executives from four companies in the race to produce a coronavirus vaccine — AstraZeneca, Johnson & Johnson, Moderna Therapeutics, and Pfizer — told lawmakers on Tuesday that they are optimistic their products could be ready by…

3 Teams Developing Coronavirus Vaccines Report Promising Results From Phase II Studies

New York Times: Three Coronavirus Vaccine Developers Report Promising Initial Results “The race for a vaccine against the coronavirus intensified on Monday as three competing laboratories released promising results from early trials in humans. Now comes the hard part: proving that any of the vaccines protects against the virus, and…